P-071 - PHARMACOKINETICS AND IMMUNOGENICITY ASSESSMENT OF A SINGLE SUBCUTANEOUS DOSE OF CASIRIVIMAB AND IMDEVIMAB IN HOUSEHOLD CONTACTS OF SARS-COV-2 INFECTED PERSONS.

H. Hassan, K. Turner, J. Davis, S. Ganguly, S. Irvin, M. Partridge, J. Nguyen, K. Lin, M. O'Brien, E. Forleo-Neto, A. Hooper, N. Al-Huniti, H. Yan, A. DiCioccio; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.